118 related articles for article (PubMed ID: 23570254)
1. Interobserver agreement and assay reproducibility of folate receptor α expression in lung adenocarcinoma: a prognostic marker and potential therapeutic target.
Bremer RE; Scoggin TS; Somers EB; O'Shannessy DJ; Tacha DE
Arch Pathol Lab Med; 2013 Dec; 137(12):1747-52. PubMed ID: 23570254
[TBL] [Abstract][Full Text] [Related]
2. Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents.
Cagle PT; Zhai QJ; Murphy L; Low PS
Arch Pathol Lab Med; 2013 Feb; 137(2):241-4. PubMed ID: 22984810
[TBL] [Abstract][Full Text] [Related]
3. Folate Receptor α Expression Level Correlates With Histologic Grade in Lung Adenocarcinoma.
Driver BR; Barrios R; Ge Y; Haque A; Tacha D; Cagle PT
Arch Pathol Lab Med; 2016 Jul; 140(7):682-5. PubMed ID: 26599808
[TBL] [Abstract][Full Text] [Related]
4. Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance.
O'Shannessy DJ; Yu G; Smale R; Fu YS; Singhal S; Thiel RP; Somers EB; Vachani A
Oncotarget; 2012 Apr; 3(4):414-425. PubMed ID: 22547449
[TBL] [Abstract][Full Text] [Related]
5. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
Kim MJ; Shin HC; Shin KC; Ro JY
Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin test.
Rüschoff J; Kerr KM; Grote HJ; Middel P; von Heydebreck A; Alves VA; Baldus SE; Büttner R; Carvalho L; Fink L; Jochum W; Lo AW; López-Ríos F; Marx A; Molina TJ; Olszewski WT; Rieker RJ; Volante M; Thunnissen E; Wrba F; Celik I; Störkel S
Arch Pathol Lab Med; 2013 Sep; 137(9):1255-61. PubMed ID: 23270410
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J
Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962
[TBL] [Abstract][Full Text] [Related]
8. CD90 is a diagnostic marker to differentiate between malignant pleural mesothelioma and lung carcinoma with immunohistochemistry.
Kawamura K; Hiroshima K; Suzuki T; Chai K; Yamaguchi N; Shingyoji M; Yusa T; Tada Y; Takiguchi Y; Tatsumi K; Shimada H; Tagawa M
Am J Clin Pathol; 2013 Oct; 140(4):544-9. PubMed ID: 24045552
[TBL] [Abstract][Full Text] [Related]
9. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
Terry J; Leung S; Laskin J; Leslie KO; Gown AM; Ionescu DN
Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
11. Expressions of insulin-like growth factor receptor-1 and insulin-like growth factor binding protein 3 in advanced non-small-cell lung cancer.
Kim YH; Sumiyoshi S; Hashimoto S; Masago K; Togashi Y; Sakamori Y; Okuda C; Mio T; Mishima M
Clin Lung Cancer; 2012 Sep; 13(5):385-90. PubMed ID: 22285568
[TBL] [Abstract][Full Text] [Related]
12. TTF-1 and Napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks.
Fatima N; Cohen C; Lawson D; Siddiqui MT
Cancer Cytopathol; 2011 Apr; 119(2):127-33. PubMed ID: 21287692
[TBL] [Abstract][Full Text] [Related]
13. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears.
Uke M; Rekhi B; Ajit D; Jambhekar NA
Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186
[TBL] [Abstract][Full Text] [Related]
14. A study of ΔNp63 expression in lung non-small cell carcinomas.
Nonaka D
Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
[TBL] [Abstract][Full Text] [Related]
15. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.
Thunnissen E; Borczuk AC; Flieder DB; Witte B; Beasley MB; Chung JH; Dacic S; Lantuejoul S; Russell PA; den Bakker M; Botling J; Brambilla E; de Cuba E; Geisinger KR; Hiroshima K; Marchevsky AM; Minami Y; Moreira A; Nicholson AG; Yoshida A; Tsao MS; Warth A; Duhig E; Chen G; Matsuno Y; Travis WD; Butnor K; Cooper W; Mino-Kenudson M; Motoi N; Poleri C; Pelosi G; Kerr K; Aisner SC; Ishikawa Y; Buettner RH; Keino N; Yatabe Y; Noguchi M
J Thorac Oncol; 2017 Feb; 12(2):334-346. PubMed ID: 27998793
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary haptoglobin: a new marker for adenocarcinomas of the lung?
Abdullah M; Marwitz S; Kähler D; Schultz H; Kugler C; Zabel P; Vollmer E; Goldmann T
Pathology; 2011 Jan; 43(1):70-2. PubMed ID: 21240070
[No Abstract] [Full Text] [Related]
17. Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas.
Nagashio R; Sato Y; Matsumoto T; Kageyama T; Satoh Y; Shinichiro R; Masuda N; Goshima N; Jiang SX; Okayasu I
Lung Cancer; 2010 Jul; 69(1):54-9. PubMed ID: 19892429
[TBL] [Abstract][Full Text] [Related]
18. Multiphoton microscopy: a potential "optical biopsy" tool for real-time evaluation of lung tumors without the need for exogenous contrast agents.
Jain M; Narula N; Aggarwal A; Stiles B; Shevchuk MM; Sterling J; Salamoon B; Chandel V; Webb WW; Altorki NK; Mukherjee S
Arch Pathol Lab Med; 2014 Aug; 138(8):1037-47. PubMed ID: 24199831
[TBL] [Abstract][Full Text] [Related]
19. Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.
Pu RT; Pang Y; Michael CW
Diagn Cytopathol; 2008 Jan; 36(1):20-5. PubMed ID: 18064689
[TBL] [Abstract][Full Text] [Related]
20. Comparison of automated cellular imaging system and manual microscopy for immunohistochemically stained cryostat sections of lung cancer specimens applying p53, ki-67 and p120.
Hilbe W; Gächter A; Duba HC; Dirnhofer S; Eisterer W; Schmid T; Mildner A; Bodner J; Wöll E
Oncol Rep; 2003; 10(1):15-20. PubMed ID: 12469137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
